443 results
Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial
30 Aug 2022
The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...
Reviewer
Dealing with complex and unique coronary cases
To gain insight on managing difficult and unusual coronary conditions, view these cases on: balloons, drills and shocks, a novel technique to manage large multiple mycotic aneurysms, rota-stenosis, left main longitudinal compression and many more!
FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial
24 Aug 2022
The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).
Reviewer
Reviewer
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
The SYNTAX II strategy: integrating best practices in complex PCI
23 Apr 2018
View the replay of this Webinar on the SYNTAX II strategy: integrating best practices in complex PCI, with J. Escaned, J. Hill and F. Ribichini.
PCRonline @ ESC Congress 2022: the interventional cardiology perspective!
18 Jul 2022
Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!
Polymer-based versus polymer-free stents in high bleeding risk patients: final 2-year results from Onyx ONE
08 Jun 2022
The results of this study show that at 2-year follow-up HBR patients undergoing PCI with a polymer-based zotarolimus-eluting stent & 1-month DAPT had similar outcomes in terms of both safety & efficacy to those with a polymer-free biolimus A9-coated stent.
Reviewer
Biolimus-coated balloon in small-vessel coronary artery disease - The BIO-RISE CHINA study
07 Jun 2022
This trial aimed to assess the safety and efficacy of a biolimus coated balloon in patients with small vessel CAD undergoing PCI.
Reviewer
Innovative coronary approches for your daily practice
20 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session presents innovative types of coronary approches used in different Clinical Case submissions: severe calcific tortuous LAD disease, the calcium challenge or IVUS-guided CTO PCI with minimum contrast...
When coronary stents failed
20 May 2022 – From EuroPCR 2022
Watch this session consisting of five clinical cases in order to discover strategies for success, solutions and advice when faced with complications when coronary stents fail.
